195 related articles for article (PubMed ID: 15155638)
1. Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.
Varaldo PB; Leite LC; Dias WO; Miyaji EN; Torres FI; Gebara VC; Armôa GR; Campos AS; Matos DC; Winter N; Gicquel B; Vilar MM; McFadden J; Almeida MS; Tendler M; McIntosh D
Infect Immun; 2004 Jun; 72(6):3336-43. PubMed ID: 15155638
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice.
Varaldo PB; Miyaji EN; Vilar MM; Campos AS; Dias WO; Armôa GR; Tendler M; Leite LC; McIntosh D
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):132-9. PubMed ID: 16965361
[TBL] [Abstract][Full Text] [Related]
3. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.
Abreu PA; Miyasato PA; Vilar MM; Dias WO; Ho PL; Tendler M; Nascimento AL
Infect Immun; 2004 Oct; 72(10):5931-7. PubMed ID: 15385496
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone.
Fonseca CT; Pacífico LG; Barsante MM; Rassi T; Cassali GD; Oliveira SC
Microbes Infect; 2006 Aug; 8(9-10):2509-16. PubMed ID: 16914349
[TBL] [Abstract][Full Text] [Related]
5. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
[TBL] [Abstract][Full Text] [Related]
6. Human IgG1 and IgG3 recognition of Schistosoma mansoni 14kDa fatty acid-binding recombinant protein.
Brito CF; Fonseca CT; Goes AM; Azevedo V; Simpson AJ; Oliveira SC
Parasite Immunol; 2000 Jan; 22(1):41-8. PubMed ID: 10744504
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization with Salmonella harboring a Sm14-based DNA vaccine does not protect mice against Schistosoma mansoni infection.
Pacheco LG; Mati VL; Castro TL; Dorella FA; Oliveira SC; Miyoshi A; de Melo AL; Azevedo V
Parasitol Int; 2008 Dec; 57(4):506-8. PubMed ID: 18538627
[TBL] [Abstract][Full Text] [Related]
8. Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.
Garcia TC; Fonseca CT; Pacifico LG; Durães Fdo V; Marinho FA; Penido ML; Caliari MV; de Melo AL; Pinto HA; Barsante MM; Cunha-Neto E; Oliveira SC
Acta Trop; 2008 Jun; 106(3):162-7. PubMed ID: 18423420
[TBL] [Abstract][Full Text] [Related]
9. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Oliveira SC
Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
[TBL] [Abstract][Full Text] [Related]
10. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
Ramos CR; Spisni A; Oyama S; Sforça ML; Ramos HR; Vilar MM; Alves AC; Figueredo RC; Tendler M; Zanchin NI; Pertinhez TA; Ho PL
Biochim Biophys Acta; 2009 Apr; 1794(4):655-62. PubMed ID: 19150418
[TBL] [Abstract][Full Text] [Related]
11. The effects of immunization with recombinant Sm14 (rSm14) in reducing worm burden and mortality of mice infected with Schistosoma mansoni.
Ribeiro F; Vieira Cdos S; Fernandes A; Araujo N; Katz N
Rev Soc Bras Med Trop; 2002; 35(1):11-7. PubMed ID: 11873255
[TBL] [Abstract][Full Text] [Related]
12. Gene structure and M20T polymorphism of the Schistosoma mansoni Sm14 fatty acid-binding protein. Molecular, functioanl, and immunoprotection analysis.
Ramos CR; Figueredo RC; Pertinhez TA; Vilar MM; do Nascimento AL; Tendler M; Raw I; Spisni A; Ho PL
J Biol Chem; 2003 Apr; 278(15):12745-51. PubMed ID: 12551912
[TBL] [Abstract][Full Text] [Related]
13. Increased immunogenicity and protection of recombinant Sm14 antigens by heat-killed Cutibacterium acnes in BALB/c mice infected with Schistosoma mansoni.
Lam HYP; Huang SP; Liang TR; Wu WJ; Cheng PC; Chang KC; Peng SY
Parasitol Int; 2022 Feb; 86():102446. PubMed ID: 34481947
[TBL] [Abstract][Full Text] [Related]
14. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
[TBL] [Abstract][Full Text] [Related]
15. r-Sm14 - pRSETA efficacy in experimental animals.
Ramos CR; Vilar MM; Nascimento AL; Ho PL; Thaumaturgo N; Edelenyi R; Almeida M; Dias WO; Diogo CM; Tendler M
Mem Inst Oswaldo Cruz; 2001; 96 Suppl():131-5. PubMed ID: 11586438
[TBL] [Abstract][Full Text] [Related]
16. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine.
Tendler M; Simpson AJ
Acta Trop; 2008; 108(2-3):263-6. PubMed ID: 18834847
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of a live Aro attenuated Salmonella vaccine strain expressing 14-kDa Schistosoma mansoni fatty acid-binding protein induced partial protection against experimental schistosomiasis.
Pacheco LG; Zucconi E; Mati VL; Garcia RM; Miyoshi A; Oliveira SC; de Melo AL; Azevedo V
Acta Trop; 2005 Aug; 95(2):132-42. PubMed ID: 15993833
[TBL] [Abstract][Full Text] [Related]
18. Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection.
Espíndola MS; Frantz FG; Soares LS; Masson AP; Tefé-Silva C; Bitencourt CS; Oliveira SC; Rodrigues V; Ramos SG; Silva CL; Faccioli LH
BMC Infect Dis; 2014 May; 14():263. PubMed ID: 24886395
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein.
Brito CF; Caldas IR; Coura Filho P; Correa-Oliveira R; Oliveira SC
Scand J Immunol; 2000 Jun; 51(6):595-601. PubMed ID: 10849370
[TBL] [Abstract][Full Text] [Related]
20. Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model.
Mossallam SF; Amer EI; Ewaisha RE; Khalil AM; Aboushleib HM; Bahey-El-Din M
BMC Infect Dis; 2015 Mar; 15():147. PubMed ID: 25887456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
